Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-15 · accession 0001104659-23-022863 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-16 | 2023-02-15 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +8,750 | 813.0K | +1% | — | |
| I | 2023-02-16 | 2023-02-15 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -8,750 | 1.04M | -0.8% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | J | A | 8,750 | — | 813,022 | D By the KBT Trust | — | — | (F1) The Reporting Person is filing this Form 4 to reflect the fact that 8,750 shares were transferred from the KBT Trust to the Reporting Person on February 15, 2023 without consideration and are now owned directly. |
| 2 | Common | Common Stock | 2023-02-15 | J | D | 8,750 | — | 1,038,950 | I | — | — | (F1) The Reporting Person is filing this Form 4 to reflect the fact that 8,750 shares were transferred from the KBT Trust to the Reporting Person on February 15, 2023 without consideration and are now owned directly. |